GLP-1 (Tirzepatide) Weight Loss in Kenya

Medical weight management with tirzepatide, lifestyle support, eligibility screening, and clinician-led follow-up in Nairobi.

Eligibility Screening Once Weekly Injection Medically Supervised

GLP-1 (Tirzepatide) in Kenya: Medical Weight Loss Support at Rayhaan Healthcare

GLP-1 (Tirzepatide) is a prescription injection that may be considered for adults who meet clinical eligibility criteria for medical weight management. At Rayhaan Healthcare, treatment begins with a consultation, BMI review, medical history, medication review, and screening for contraindications before any programme is recommended.

Weight loss injections are not a stand-alone shortcut. The best outcomes usually come from structured follow-up, nutrition guidance, physical activity planning, side-effect monitoring, and regular review of progress. Our team helps patients understand realistic expectations, safe use, dose escalation, and when an alternative approach may be more appropriate.

  • Clinical leadership from Dr. Mustafa Alibhai for weight management and bariatric pathways.
  • Options include non-surgical weight loss, medication review, gastric balloon, and bariatric surgery where clinically appropriate.
  • Consultations available at Rayhaan Healthcare in Parklands, Nairobi.
22.5%Study-reported weight loss in selected eligible adults
OnceWeekly self-injection (subcutaneous)
DualGLP-1 & GIP hormone activation

Dual Hormone Action

GLP-1 (Tirzepatide) is a dual GLP-1 and GIP receptor agonist involved in appetite, satiety, and blood sugar regulation. Under medical supervision, this dual mechanism may help:

  • Suppresses appetite and reduces food cravings
  • Slows gastric emptying (you feel full longer)
  • Improves insulin sensitivity and blood sugar control
  • Support weight reduction alongside nutrition and activity changes
  • Support monitoring of cardiometabolic risk markers
  • Support review of cholesterol and triglyceride trends during follow-up
Start GLP-1 (Tirzepatide) Programme

Who Is Eligible?

Suitable For

  • BMI >= 27 with at least one weight-related condition (diabetes, hypertension, high cholesterol)
  • BMI >= 30 (obesity) regardless of other conditions
  • Adults seeking medically supervised weight loss
  • Patients who have not responded to diet and exercise alone

Not Suitable For

  • Personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia type 2 (MEN 2)
  • Known allergy to tirzepatide
  • Pregnancy or breastfeeding

Possible Side Effects

20-40% Nausea
18-23% Diarrhoea
10-18% Vomiting
10-16% Constipation

Side effects are usually mild, occur early in treatment, and reduce as the dose is titrated gradually.

Treatment Journey

What to Expect Before Starting GLP-1 (Tirzepatide)

1. Medical Assessment

Your consultation reviews BMI, weight history, current medications, medical conditions, previous weight loss attempts, and treatment goals.

2. Baseline Checks

Your clinician may recommend lab tests or additional checks, especially if diabetes, high cholesterol, hypertension, or other conditions are present.

3. Dose and Use Guidance

If suitable, you receive guidance on injection timing, safe storage, dose escalation, missed doses, and symptoms that should be reported.

4. Nutrition Support

Medication is paired with a realistic eating plan focused on protein, hydration, fibre, portion control, and long-term habit change.

5. Progress Review

Follow-up helps track weight, tolerance, side effects, appetite changes, waist measurements, and whether treatment remains appropriate.

6. Long-Term Plan

Your plan may include medication continuation, dose adjustment, weight maintenance support, or referral for other treatments if needed.

Book Your GLP-1 (Tirzepatide) Consultation

Medical screening included. Start your GLP-1 (Tirzepatide) journey at Rayhaan Healthcare.

We welcome all major insurance providers — AAR, Jubilee, CIC, UAP, Resolution, Britam, MUA, AON Minet & more. Verify your cover →

WhatsApp